LIFE IN THE END ZONE

The most promising treatment of Alzheimer’s disease to date uses monoclonal antibodies to rid the brain of amyloid plaques. These plaques a...

Kudos to Judith Graham of Kaiser Health News for yet again identifying a new development that has the potential to enormously affect the me...

Nearly 30 years have passed since Congress passed the Patient Self-Determination Act, enthroning advance care planning as an important part...

Honoring patient preferences, which is shorthand for providing an approach to medical treatment consistent with what patients say they want...

I once called MedPAC the most influential organization in the medical arena that most Americans have never heard of. That was in a blog pos...

Recent reports indicate that Congress will try to slash Medicare in order to balance the budget—making older people and disabled people sho...

Two short essays in this week’s  New England Journal of Medicine  present differing perspectives on how to treat a desperately ill woman w ...

Several years ago, the public health community launched an initiative to persuade pharmacies to stop selling cigarettes. Responding to stea...

This week, the Massachusetts Coalition for Serious Illness Care released the results of a survey of state residents about advance care pla...

Over the past ten years, people with advanced dementia have gradually come to be recognized as dying. Death may not come in a day or a mont...